Literature DB >> 8867247

Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics.

Istvan Nagy1, Clifford J Woolf.   

Abstract

The action of lignocaine on nociceptive transmission in the spinal cord has been studied in vitro using ventral root potential (VRP) recordings from 10-12-day-old rat hemisected spinal cord preparations. Single-shock stimulation of a dorsal root at intensities sufficient to activate high-threshold C-primary afferent fibres elicited VRPs lasting for 15-20 sec in the corresponding ventral root. The VRP consisted of 3 distinct parts: the early, slow and prolonged components, as previously described (Thompson et al. 1992), where the early represents A beta fibre-evoked mono- and polysynaptic responses lasting for tens of milliseconds, the slow is a largely N-methyl-D-aspartic acid (NMDA) receptor-mediated small-calibre afferent-generated component, lasting for about 1.5 sec, and the prolonged is a neurokinin receptor-mediated long-lasting component generated by high-threshold fibres. Lignocaine superfusion (40-60 microM) significantly and reversibly reduced the slow and prolonged components of the C fibre-evoked VRP in a dose-dependent manner without any effect on the early or A beta fibre-mediated component of the VRP. The amplitude of the cumulative VRP generated by repetitive inputs (1 and 10 Hz) was also significantly reduced as was the depolarization produced by bath application of NMDA (100 microM) or substance P (SP, 1 microM) in the presence or absence of tetrodotoxin (TTX) (300 nM). At this dose range lignocaine had no effect on the compound action potential (CAP) elicited by stimulating the sciatic nerve and recorded on the dorsal root. The CAP was only significantly reduced with a 300 microM dose of lignocaine. Application of the opiate, glycine, GABAA and GABAB receptor antagonists, naloxone (1 microM), strychnine (100 microM), bicuculline (100 microM) and phaclofen (100 microM) did not alter the depressant effects of lignocaine on the VRP. Low concentrations of lignocaine have a selective action on nociceptive transmission in the spinal cord which is different and more potent than its local anaesthetic conduction blockade in the periphery. This includes a reduction of direct or synaptically driven NMDA- and NK receptor-mediated post-synaptic depolarizations indicating that this class of sodium channel blockers may be potentially useful as analgesic agents, possibly acting on TTX-resistant sodium ion channels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8867247     DOI: 10.1016/0304-3959(95)00072-0

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  19 in total

1.  Lidocaine infusion adjunct to total intravenous anesthesia reduces the total dose of propofol during intraoperative neurophysiological monitoring.

Authors:  Tod B Sloan; Paul Mongan; Clark Lyda; Antoun Koht
Journal:  J Clin Monit Comput       Date:  2013-08-31       Impact factor: 2.502

Review 2.  [Intravenous administration of lidocaine for perioperative analgesia. Review and recommendations for practical usage].

Authors:  A Herminghaus; M Wachowiak; W Wilhelm; A Gottschalk; K Eggert; A Gottschalk
Journal:  Anaesthesist       Date:  2011-02       Impact factor: 1.041

3.  Serum concentration of lidocaine after transversus abdominis plane block.

Authors:  Naoko Kato; Yoshihiro Fujiwara; Misako Harato; Shuji Kurokawa; Yasuyuki Shibata; Jun Harada; Toru Komatsu
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

4.  Intraperitoneal and intravenous lidocaine for effective pain relief after laparoscopic appendectomy: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Tae Han Kim; Hyun Kang; Joon Hwa Hong; Jun Seok Park; Chong Wha Baek; Jin Yun Kim; Yong Hun Jung; Hyang Kyoung Kim
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

Review 5.  Perioperative Use of Intravenous Lidocaine.

Authors:  Marc Beaussier; Alain Delbos; Axel Maurice-Szamburski; Claude Ecoffey; Luc Mercadal
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 6.  Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials.

Authors:  Grace C McCarthy; Sohair A Megalla; Ashraf S Habib
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

7.  Multiple ionic mechanisms mediate inhibition of rat motoneurones by inhalation anaesthetics.

Authors:  J E Sirois; J J Pancrazio; C Lynch; D A Bayliss
Journal:  J Physiol       Date:  1998-11-01       Impact factor: 5.182

8.  Cardiopulmonary Effects of Constant-Rate Infusion of Lidocaine for Anesthesia during Abdominal Surgery in Goats.

Authors:  Lais M Malavasi; Stephen A Greene; John M Gay; Tammy L Grubb
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

9.  Durability of Benefit From Repeated Intravenous Lidocaine Infusions in Fibromyalgia Patients: A Case Series and Literature Review.

Authors:  David M Marks; Amy Newhouse
Journal:  Prim Care Companion CNS Disord       Date:  2015-09-17

10.  Evaluation of the effects of neural therapy in patients diagnosed with fibromyalgia.

Authors:  Turgay Altınbilek; Rabia Terzi; Aynur Başaran; Sena Tolu; Seher Küçüksaraç
Journal:  Turk J Phys Med Rehabil       Date:  2019-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.